Kissei Pharmaceutical Co. Ltd. (4547)
Market Closed
12 Dec, 06:00
JPX JPX Primary ¥
4,565. 00
-20
-0.44%
¥
157.52B Market Cap
- P/E Ratio
180% Div Yield
42,500 Volume
- Eps
¥ 4,585
Previous Close Day Range
4,565 4,670
Year Range
3,445 4,780
Want to track 4547 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 47 days
Summary
4547 closed Friday lower at ¥4,565, a decrease of 0.44% from Thursday's close, completing a monthly increase of 0.33% or ¥15. Over the past 12 months, 4547 stock gained 9.21%.
4547 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next estimated payment will be in In 5 months on Jun 01, 2026 for a total of ¥60.
The last earnings report, released on Nov 03, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jan 30, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on JPX (JPY).
Kissei Pharmaceutical Co. Ltd. (4547) FAQ
What is the stock price today?
The current price is ¥4,565.00.
On which exchange is it traded?
Kissei Pharmaceutical Co. Ltd. is listed on JPX.
What is its stock symbol?
The ticker symbol is 4547.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 180%.
What is its market cap?
As of today, the market cap is 157.52B.
When is the next earnings date?
The next earnings report will release on Jan 30, 2026.
Has Kissei Pharmaceutical Co. Ltd. ever had a stock split?
No, there has never been a stock split.
Kissei Pharmaceutical Co. Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Mutsuo Kanzawa CEO | JPX Exchange | - ISIN |
| JP Country | 1,779 Employees | 29 Sep 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Kissei Pharmaceutical Co., Ltd., based in Matsumoto, Japan, is a reputable entity in the pharmaceutical industry, focusing primarily on the Japanese market. Since its establishment in 1946, originally known as Kissei Yakuhin Kogyo Co., Ltd., the company has made significant strides in research, development, manufacturing, and sales of pharmaceuticals. Renamed in October 1964, Kissei Pharmaceutical has expanded its reach and diversification into various related sectors, including system development, information processing, construction contracting, and even food manufacturing, showcasing its versatility and commitment to innovation in healthcare and related services.
Products and Services
Kissei Pharmaceutical offers a wide range of pharmaceutical products and services, detailed as follows:
- Kalogra tablets: Prescribed for the treatment of ulcerative colitis, addressing inflammation and ulcers in the innermost lining of the large intestine and rectum.
- Tabuneos capsules: Developed for patients suffering from microscopic polyangiitis and granulomatous polyangiitis, offering hope in managing these rare, autoimmune diseases.
- Minirin Melt OD tablets, Malizeb tablets, Tavaris tablets, and Beova tablets: Catering to a variety of conditions from chronic idiopathic thrombocytopenic purpura, demonstrating the company's broad focus on developing solutions for complex health issues.
- Darbepoetin Alfa BS injection JCR: An innovative solution for the treatment of renal anemia, underscoring Kissei’s commitment to addressing chronic conditions.
- Product Pipeline: With drugs like CG0070 for bladder cancer, Linzagolix for uterine fibroids and endometriosis, and various other drugs in different stages of clinical trials, Kissei Pharmaceutical is actively working on pioneering treatments for the future.
- Additional Ventures: Beyond pharmaceuticals, Kissei engages in a wide array of other businesses, including food products specially designed for medical needs, equipment rentals, insurance, and even noodle manufacturing. The company also invests in construction of facilities and development of computer systems and cloud services, highlighting its diverse business interests aligned with healthcare and technological innovation.
Contact Information
Address: 19-48, Yoshino
Phone: 81 263 25 9081
Website: https://www.kissei.co.jp
2025 © Marketlog. All Rights Reserved.
